Your browser doesn't support javascript.
loading
Inappropriate Expression of PD-1 and CTLA-4 Checkpoints in Myeloma Patients Is More Pronounced at Diagnosis: Implications for Time to Progression and Response to Therapeutic Checkpoint Inhibitors.
Kulikowska de Nalecz, Anna; Ciszak, Lidia; Usnarska-Zubkiewicz, Lidia; Pawlak, Edyta; Frydecka, Irena; Szmyrka, Magdalena; Kosmaczewska, Agata.
Afiliación
  • Kulikowska de Nalecz A; Hematology and Hematological Oncology Department, Provincial Hospital, 45-061 Opole, Poland.
  • Ciszak L; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.
  • Usnarska-Zubkiewicz L; Department of Hematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, 50-367 Wroclaw, Poland.
  • Pawlak E; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.
  • Frydecka I; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.
  • Szmyrka M; Department of Rheumatology and Internal Diseases, Wroclaw Medical University, 50-556 Wroclaw, Poland.
  • Kosmaczewska A; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.
Int J Mol Sci ; 24(6)2023 Mar 17.
Article en En | MEDLINE | ID: mdl-36982802

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Suiza